Quantcast

Latest Parexel Stories

2014-10-22 12:30:21

VANCOUVER, BC and PLYMOUTH, MI, Oct. 22, 2014 /PRNewswire/ - ProNAi Therapeutics Inc., a private company dedicated to developing and commercializing a new class of therapies based on its proprietary DNAi® platform, today announced that it has added five seasoned executives to its senior management team. -- Dr. Angie You, Chief Business & Strategy Officer & Head of Commercial -- Wendy Chapman, Senior Vice President, Clinical Operations...

2014-10-03 12:25:20

BOSTON, Oct. 3, 2014 /PRNewswire/ -- PAREXEL International Corporation (Nasdaq: PRXL)("PAREXEL" or the "Company"), a global clinical research organization, announced today that the Company has acquired all of the outstanding equity securities of privately-owned ClinIntel, a provider of clinical Randomization and Trial Supply Management (RTSM) services, based in the United Kingdom. ClinIntel's offerings will be combined into the ClinPhone(® )RTSM suite and are designed to make...

2014-10-01 08:33:18

BOSTON, Oct. 1, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the First Quarter of Fiscal Year 2015 on Wednesday, October 29(th), 2014 after the close of the stock market. The announcement will be available on PAREXEL's website at www.PAREXEL.com and on the PRNewswire website at www.prnewswire.com. PAREXEL will host a conference call and live webcast at 10:00 a.m. EDT on Thursday, October 30(th), 2014 to discuss the results....

2014-09-11 08:27:36

Life sciences service providers leverage PAREXEL's eClinical solutions to simplify drug development for customers through technology partnership initiative BOSTON, Sept. 11, 2014 /PRNewswire/ -- PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that clinical technology companies CRF Health and Clinical Ink have joined its Perceptive® Partner Program. Through the program, technology, consulting, reseller and training companies, as...

2014-09-04 08:29:33

BOSTON, Sept. 4, 2014 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the appointment of Dr. Tracy Tsuetaki as Senior Vice President for Peri/Post-Approval Services and PAREXEL Consulting. He will oversee the strategy and operational management for both businesses. He will also serve on PAREXEL's Business Review Committee, the Company's senior-most leadership team, and assist in developing and...

2014-09-02 12:28:35

NEW YORK CITY, New York, September 2, 2014 /PRNewswire/ -- Persistence Market Research(http://www.persistencemarketresearch.com) "Global Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019" the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Browse the full Global Market Study...

2014-08-12 08:31:11

Consulting company hires Mr. Church to meet growing demand for R&D and Commercial Strategy RALEIGH-DURHAM, N.C., Aug. 12, 2014 /PRNewswire/ -- Kineticos Life Sciences today announced the hiring of Christopher Church as a new Managing Director. Mr. Church adds life sciences expertise in areas such as feasibility analysis (corporate strategy, portfolio, and product-levels), asset valuation, market positioning, alliance prospecting, and negotiation and management pricing strategy to the...

2014-08-11 12:27:45

AstraZeneca, Boehringer Ingelheim, Eli Lilly & Company, Ferring Pharmaceuticals, Inc., Forest Laboratories, Inc., GlaxoSmithKline, Novartis, Novo Nordisk, Pearl Therapeutics, Pfizer, Sanofi, Chiltern International, ICON plc, INC Research, inVentiv Health, Parexel International, Pharmaceutical Research Associates (PRA), Quintiles, and Target Health Inc. ELLICOTT CITY, Md., Aug. 11, 2014 /PRNewswire/ -- The Society for Clinical Research Sites (SCRS), the trade organization representing...

2014-08-06 16:29:37

BOSTON, Aug. 6, 2014 /PRNewswire/ -- Fourth Quarter Fiscal Year 2014 Results (compared to Fourth Quarter Fiscal Year 2013) -- 10.2% growth in consolidated service revenue to $510.6 million -- GAAP operating margin of 11.5%; adjusted operating margin of 11.2% (up 260 basis points) -- GAAP diluted earnings per share of $0.70 grew 34.6%; adjusted earnings per share of $0.65 grew 30.0% -- Net new business wins of $592.5 million; net book-to-bill...

2014-07-30 23:12:30

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Rachel Garrido of Parexel will speak at Pharmica’s CRO Management and Partnership Conference on November 18, 2014 in Philadelphia, Pa. Philadelphia, PA (PRWEB) July 30, 2014 As part of its continued service to the industry, Pharmica Consulting will host its CRO Management and Partnership Conference on November 18 in Philadelphia, Pa. The conference will focus on how sponsors...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.